期刊文献+

早发型重度子痫前期期待治疗的预后评估 被引量:3

EXPECTANT TREATMENT OF EARLY ONSET SEVERE PREECLAMPSIA:AN ASSESSMENT OF ITS PROGNOSIS
下载PDF
导出
摘要 目的探讨早发型重度子痫前期期待治疗对母儿结局的影响。方法对我院收治的经期待治疗的280例早发型重度子痫前期病人临床资料进行回顾性分析。将病人按发病孕龄分为4组:Ⅰ组40例,发病孕龄<28周;Ⅱ组68例,发病孕龄28~29+6周;Ⅲ组77例,发病孕龄30~31+6周;Ⅳ组95例,发病孕龄32~33+6周。比较各组孕妇期待治疗时间、并发症发生情况及围生结局。结果 4组孕妇期待治疗时间差异有显著性(F=23.44,P<0.05);4组并发症发生率差异无显著性(χ2=5.607,P>0.05);4组围生儿死亡率随孕周增加而下降,各组间比较差异有显著性(χ2=15.739~104.239,P<0.01);Ⅰ组终止妊娠方式以阴道分娩为主,其他3组以剖宫产为主,Ⅰ组与其他3组剖宫产率比较差异有显著性(χ2=36.487~74.859,P<0.01)。结论早发型重度子痫前期期待治疗是可行的,但应在严密监测母儿状况的同时,选择适宜时机终止妊娠,终止妊娠的主要方法是剖宫产。 Objective To explore the influence of expectant management on mother and fetus of early-onset severe preeclampsia(EOSP).Methods A retrospective analysis was carried out in 280 patients with EOSP received expectant management in our hospital,who were divided into four groups according to gestational age(GA) when onset of the disease: group Ⅰ,GA of <28 weeks;group Ⅱ,68 cases with GA of 28-29+6 weeks;group Ⅲ,77 cases with GA of 30-31+6 weeks;group Ⅳ,95 cases with GA of 32-33+6 weeks.The time of expectant therapy,complications and the perinatal outcomes among the four groups were compared.Results The time of therapy among the four groups was significantly different(F=23.44,P<0.05);the difference of complications among them was not significant(χ2=5.607,P>0.05);the perinatal mortality rate decreased along with the increase of gestational weeks(χ2=15.739-104.239,P<0.01);the main modes of termination of pregnancy were vaginal delivery in group Ⅰ;cesarean sections in the other three groups,the differences between group I and the other three groups were significant(χ2=36.487-74.859,P<0.01).Conclusion The expectant management is feasible for EOSP,but the status of mother and fetus should be closely monitored.It is a must to select an optimal occasion for termination of pregnancy,uterine-incision delivery being the main method.
出处 《齐鲁医学杂志》 2013年第2期132-135,共4页 Medical Journal of Qilu
关键词 子痫 妊娠并发症 治疗 预后 eclampsia therapy pregnancy complications prognosis
  • 相关文献

参考文献13

  • 1RAYMOND D, PETERSON E. A critical review of early onset and late-onset preeclampsia[J].Obstetrical & Gynecological Survey, 2011,66(8) :497-506.
  • 2HALL D R, ODENDAAL H J, STEYN D W. Delivery of patients with early onset, severe pre-eclampsia[J]. Int J Gynaecol Obstet, 2001,74(2):143- 150.
  • 3WITHAGEN M I, WALLENBURG H C, STEEGERS E A, et al. Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia[J]. BJOG: an International Journal of Obstetrics and Gynaecology, 2005,112(7) :910-914.
  • 4米海平.早发型重度子痫前期的保守治疗及临床结局[J].实用临床医学(江西),2008,9(8):78-79. 被引量:9
  • 5BRANCH D W, ANDRES R, DIORE K B, et al. The association of antiphospholipid antibodies with severe preeclampsia [J]. Obstet Gynecol, 1989,73(4):541- 545.
  • 6HADDAD B, DEIS S, GOFFINET F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gcstation[J]. American Journal of Obstetrics and Gynecology, 2004, 190 (6) : 1590-1595.
  • 7兰淑海,牛秀敏.早发型重度子痫前期78例临床分析[J].中国妇幼保健,2011,26(12):1793-1795. 被引量:18
  • 8黄玲,叶元华.子痫前期胎盘组织PD-ECGF与MVD表达及其意义[J].齐鲁医学杂志,2011,26(5):448-450. 被引量:3
  • 9ROBERTS J M, HUBEL C A. The two stage model of preeclampsia: variations on the theme[J].Placenta, 2009, 30 (Suppl A) :S32 -S37.
  • 10HUPPERTZ B. Placental origins of preeclampsia: challenging the current hypothesis[J].Hypertension, 2008,51(4):970- 975.

二级参考文献37

共引文献356

同被引文献32

  • 1SAITO S, NAKASHIMA A, SHIMA T, et al. Thl/Th2/ Thl7 and regulatory T-cell paradigm in pregnancy[J]. Am JReprod Immunol, 2010,63(6) : 601-610.
  • 2LAU S Y, GUILD S J, BARRETT C J, et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are al- tered in preeclampsia: a systematic review and meta-analysis [J]. Am J Reprod Immunol, 2013,70(5) :412-427.
  • 3KALINDERIS M, PAPANIKOLAOU A, KALINDERI K, et al. Elevated serum levels of interleukin-6, interleukin-l[? and human ehorionic gonadotropin in preeclampsia[J]. Am J Re- prod Immunol, 2011,66(6) :468-475.
  • 4ZHANG Z, GAO Y, ZHANG L, et al. Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia :-J:. Hypertens Pregnancy, 2013,32(3) :270-280.
  • 5LUO J Y, ZHONG Y, CAO J C, et al. Efficacy of oral colon- specific delivery capsule o{ low-molecular-weight heparin on ul- cerative colitisFJ:.Biomed Pharmacother, 2011,65(2) : 111.
  • 6LEE J H, KIM C H, SEO G H, et al. Heparin attenuates the ex- pression of TNFalpha-induced cerebral endothelial cell adhesion molecule[J]. Korean J Physiol Pharmacol, 2008,12(5) :231 236.
  • 7XIE F, HU Y, TURVEY S, et al. Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre- eclampsia[J]. BJOG, 2010,117 : 99-108.
  • 8STEEGERS E A, VON DADELSZEN P, DUVEKOT J J, et al. Preeclampsia[J]. Lancet, 2010,376 .. 631 -644.
  • 9DEKKER G A, SIBAI B M. Etiology and pathogenesis of pree- clampsia= current conceptsT-J. Am J Obstet Gynecol, 1998, 1791-1359 1375.
  • 10LACHMEIJER A, DEKKER G A, PALS G, et al. Searching for preeclampsia genes: the current position[J]. European Journal of Obstetrics Gynecology and Reproductive Biology, 2002,105(2) : 94-113.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部